Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
Transplantation|February 1, 2013
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationYan Topilsky, Eugenia Raichlin, Tal Hasin, et al.
Pulmonary Circulation|November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertensionRobert P Frantz, Raymond L Benza, Richard N Channick, et al.
Journal of the American College of Cardiology|December 11, 2012
Readmissions after implantation of axial flow left ventricular assist deviceTal Hasin, Yariv Marmor, Walter Kremers, et al.
The American Journal of Cardiology|September 8, 2014
Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failureTal Hasin, Sudhir S Kushwaha, Timothy G Lesnick, et al.
European Journal of Heart Failure|July 26, 2024
Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertensionYogesh N V Reddy, Hilary Dubrock, Paul M Hassoun, et al.
Mayo Clinic Proceedings|December 14, 2002
Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacityRay W Squires, Tat-Chi Leung, Nancy S Cyr, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Journal of the American College of Cardiology|October 25, 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Chest|February 14, 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary HypertensionAparna Balasubramanian, A Brett Larive, Evelyn M Horn, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
Transplantation|February 1, 2013
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationYan Topilsky, Eugenia Raichlin, Tal Hasin, et al.
Pulmonary Circulation|November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertensionRobert P Frantz, Raymond L Benza, Richard N Channick, et al.
Journal of the American College of Cardiology|December 11, 2012
Readmissions after implantation of axial flow left ventricular assist deviceTal Hasin, Yariv Marmor, Walter Kremers, et al.
The American Journal of Cardiology|September 8, 2014
Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failureTal Hasin, Sudhir S Kushwaha, Timothy G Lesnick, et al.
European Journal of Heart Failure|July 26, 2024
Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertensionYogesh N V Reddy, Hilary Dubrock, Paul M Hassoun, et al.
Mayo Clinic Proceedings|December 14, 2002
Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacityRay W Squires, Tat-Chi Leung, Nancy S Cyr, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Journal of the American College of Cardiology|October 25, 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Chest|February 14, 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary HypertensionAparna Balasubramanian, A Brett Larive, Evelyn M Horn, et al.
Pageof 25